A DTC 'Flashpoint'

Some pharmacogenomic DTC tests that aim to assess a person's response to particular medicines may end up available only through a doctor's prescription, says New Scientist's Peter Aldhous. As FDA moves toward regulating the DTC genetic testing industry, the question of whether pharmacogenomic tests in particular should be regulated is "emerging as a flashpoint," Aldhous says.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.